Financial statements Apteki Pharma
Balance sheet data of APTEKI PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 566 055,47 | 1 351 430,58 | 1 353 944,63 | 811 124,06 | 847 622,17 | 4 617 594,72 |
| A. Fixed assets | 82 757,24 | 74 733,25 | 66 709,26 | 54 035,27 | 92 469,61 | 67 393,61 |
| B. Current assets | 1 483 298,23 | 1 276 697,33 | 1 287 235,37 | 757 088,79 | 755 152,56 | 4 550 201,11 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 566 055,47 | 1 351 430,58 | 1 353 944,63 | 811 124,06 | 847 622,17 | 4 617 594,72 |
| A. Equity | 829 872,74 | 631 149,36 | 420 305,26 | 253 013,80 | 11 048,73 | -1 371 602,89 |
| B. Liabilities and provisions for liabilities | 736 182,73 | 720 281,22 | 933 639,37 | 558 110,26 | 836 573,44 | 5 989 197,61 |
| I. Long-term liabilities | - | - | 38 823,03 | 0,00 | 0,00 | 3 775 211,04 |
| II. Short-term liabilities | 736 182,73 | 720 281,22 | 894 816,34 | 558 110,26 | 836 573,44 | 2 213 986,57 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.